{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,10]],"date-time":"2026-01-10T07:39:59Z","timestamp":1768030799184,"version":"3.49.0"},"reference-count":48,"publisher":"Japanese Society of Toxicology","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J. Toxicol. Sci."],"published-print":{"date-parts":[[2026]]},"DOI":"10.2131\/jts.51.31","type":"journal-article","created":{"date-parts":[[2026,1,5]],"date-time":"2026-01-05T22:10:45Z","timestamp":1767651045000},"page":"31-44","source":"Crossref","is-referenced-by-count":0,"title":["Evaluation of toxicokinetic interactions mediated by plasma protein binding during amoxapine intoxication"],"prefix":"10.2131","volume":"51","author":[{"given":"Akifumi","family":"Okamoto","sequence":"first","affiliation":[{"name":"Department of Toxicology, Showa Medical University Graduate School of Pharmacy"},{"name":"Showa Medical University Pharmacological Research Center"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshitaka","family":"Yamazaki","sequence":"additional","affiliation":[{"name":"Department of Toxicology, Showa Medical University Graduate School of Pharmacy"},{"name":"Showa Medical University Pharmacological Research Center"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Natsumi","family":"Hattori-Usami","sequence":"additional","affiliation":[{"name":"Department of Toxicology, Showa Medical University Graduate School of Pharmacy"},{"name":"Showa Medical University Pharmacological Research Center"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenji","family":"Momo","sequence":"additional","affiliation":[{"name":"Division of Clinical Research, Department of Hospital Pharmaceutics, Showa Medical University School of Pharmacy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Asuka","family":"Kaizaki-Mitsumoto","sequence":"additional","affiliation":[{"name":"Department of Toxicology, Showa Medical University Graduate School of Pharmacy"},{"name":"Showa Medical University Pharmacological Research Center"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satoshi","family":"Numazawa","sequence":"additional","affiliation":[{"name":"Department of Toxicology, Showa Medical University Graduate School of Pharmacy"},{"name":"Showa Medical University Pharmacological Research Center"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"898","reference":[{"key":"1","unstructured":"Abad-Santos, F., Carcas, A.J., F-Capit\u00e1n, C. and Frias, J. (1995): Retroperitoneal haematoma in a patient treated with acenocoumarol, phenytoin and paroxetine. Clin. Lab. Haematol., <b>17<\/b>, 195-197."},{"key":"2","doi-asserted-by":"crossref","unstructured":"Alvarez, P.A., Egozcue, J., Sleiman, J., Moretti, L., Di Girolamo, G. and Keller, G.A. (2012): Severe neutropenia in a renal transplant patient suggesting an interaction between mycophenolate and fenofibrate. Curr. Drug Saf., <b>7<\/b>, 24-29.","DOI":"10.2174\/157488612800492708"},{"key":"3","doi-asserted-by":"crossref","unstructured":"Ansong, S., Doad, J., Igweonu-Nwakile, E.O. and Okafor, C. (2025): Drug-Drug Interaction of Warfarin and Doxycycline Leading to a Large Rectus Sheath Hematoma. Cureus, <b>17<\/b>, e81312.","DOI":"10.7759\/cureus.81312"},{"key":"4","doi-asserted-by":"crossref","unstructured":"Anton, R.F. Jr. and Burch, E.A. Jr. (1993): Response of psychotic depression subtypes to pharmacotherapy. J. Affect. Disord., <b>28<\/b>, 125-131.","DOI":"10.1016\/0165-0327(93)90041-H"},{"key":"5","doi-asserted-by":"crossref","unstructured":"Bird, J. and Carmona, C. (2008): Probable interaction between warfarin and torsemide. Ann. Pharmacother., <b>42<\/b>, 1893-1898.","DOI":"10.1345\/aph.1L306"},{"key":"6","doi-asserted-by":"crossref","unstructured":"Bock, J.L., Cummings, K.C. and Jatlow, P.I. (1982): Amoxapine overdose: a case report. Am. J. Psychiatry, <b>139<\/b>, 1619-1620.","DOI":"10.1176\/ajp.139.12.1619"},{"key":"7","doi-asserted-by":"crossref","unstructured":"Bosse, G.M. and Matyunas, N.J. (1999): Delayed toxidromes. J. Emerg. Med., <b>17<\/b>, 679-690.","DOI":"10.1016\/S0736-4679(99)00064-5"},{"key":"8","doi-asserted-by":"crossref","unstructured":"Browne, J.L., Tsuang, M.T. and Perry, P.J. (1982): Amoxapine neurotoxicity: a case report with long-term follow-up. Drug Intell. Clin. Pharm., <b>16<\/b>, 404-407.","DOI":"10.1177\/106002808201600509"},{"key":"9","doi-asserted-by":"crossref","unstructured":"Castanares-Zapatero, D., Gillard, N., Capron, A., Haufroid, V. and Hantson, P. (2016): Reversible cardiac dysfunction after venlafaxine overdose and possible influence of genotype and metabolism. Forensic Sci. Int., <b>266<\/b>, e48-e51.","DOI":"10.1016\/j.forsciint.2016.05.030"},{"key":"10","doi-asserted-by":"crossref","unstructured":"Ceciliani, F. and Pocacqua, V. (2007): The acute phase protein alpha1-acid glycoprotein: a model for altered glycosylation during diseases. Curr. Protein Pept. Sci., <b>8<\/b>, 91-108.","DOI":"10.2174\/138920307779941497"},{"key":"11","doi-asserted-by":"crossref","unstructured":"Cohen, B.M., Harris, P.Q., Altesman, R.I. and Cole, J.O. (1982): Amoxapine: neuroleptic as well as antidepressant? Am. J. Psychiatry, <b>139<\/b>, 1165-1167.","DOI":"10.1176\/ajp.139.9.1165"},{"key":"12","doi-asserted-by":"crossref","unstructured":"Deitchman, A.N., Singh, R.S. and Derendorf, H. (2018): Nonlinear Protein Binding: Not What You Think. J. Pharm. Sci., <b>107<\/b>, 1754-1760.","DOI":"10.1016\/j.xphs.2018.03.023"},{"key":"13","doi-asserted-by":"crossref","unstructured":"de la Torre, R., Farr\u00e9, M., Ortu\u00f1o, J., Mas, M., Brenneisen, R., Roset, P.N., Segura, J. and Cam\u00ed, J. (2000): Non-linear pharmacokinetics of MDMA (\u2018ecstasy\u2019) in humans. Br. J. Clin. Pharmacol., <b>49<\/b>, 104-109.","DOI":"10.1046\/j.1365-2125.2000.00121.x"},{"key":"14","unstructured":"DRUGBANK 5.1.8: https:\/\/go.drugbank.com\/"},{"key":"15","doi-asserted-by":"crossref","unstructured":"Elias, J.H., Olney, L.W., Frederick, P.M., Yokote, M. and Herur, J. (2024): Supratherapeutic International Normalized Ratio in a Patient on Warfarin Following Initiation of Brexpiprazole Pharmacotherapy: A Case Report. Cureus, <b>16<\/b>, e70457.","DOI":"10.7759\/cureus.70457"},{"key":"16","doi-asserted-by":"crossref","unstructured":"Ferry, D.G., Caplan, N.B. and Cubeddu, L.X. (1986): Interaction between antidepressants and alpha 1-adrenergic receptor antagonists on the binding to alpha 1-acid glycoprotein. J. Pharm. Sci., <b>75<\/b>, 146-149.","DOI":"10.1002\/jps.2600750208"},{"key":"17","doi-asserted-by":"crossref","unstructured":"Fonck, K., Haenebalcke, C., Hemeryck, A., Belpaire, F., Jordaens, L., Calle, P. and Buylaert, W. (1998): ECG changes and plasma concentrations of propafenone and its metabolites in a case of severe poisoning. J. Toxicol. Clin. Toxicol., <b>36<\/b>, 247-251.","DOI":"10.3109\/15563659809028948"},{"key":"18","doi-asserted-by":"crossref","unstructured":"Goldberg, M.J. and Spector, R. (1982): Amoxapine overdose: report of two patients with severe neurologic damage. Ann. Intern. Med., <b>96<\/b>, 463-464.","DOI":"10.7326\/0003-4819-96-4-463"},{"key":"19","doi-asserted-by":"crossref","unstructured":"Hasan, S.A. (2007): Interaction of doxycycline and warfarin: an enhanced anticoagulant effect. Cornea, <b>26<\/b>, 742-743.","DOI":"10.1097\/ICO.0b013e318053387f"},{"key":"20","doi-asserted-by":"crossref","unstructured":"Hashimoto, T., Kaneda, Y., Ozaki, A., Hori, A. and Tsuchiya, T. (2022): Eleven-Year Trend of Drug and Chemical Substance Overdose at a Local Emergency Hospital in Japan. Cureus, <b>14<\/b>, e32475.","DOI":"10.7759\/cureus.32475"},{"key":"21","doi-asserted-by":"crossref","unstructured":"Holladay, J.W., Dewey, M.J. and Yoo, S.D. (1996): Steady-state kinetics of imipramine in transgenic mice with elevated serum AAG levels. Pharm. Res., <b>13<\/b>, 1313-1316.","DOI":"10.1023\/A:1016005529420"},{"key":"22","doi-asserted-by":"crossref","unstructured":"Huang, Z. and Ung, T. (2013): Effect of alpha-1-acid glycoprotein binding on pharmacokinetics and pharmacodynamics. Curr. Drug Metab., <b>14<\/b>, 226-238.","DOI":"10.2174\/1389200211314020011"},{"key":"23","unstructured":"Ide, A. (2006): Case of amoxapine-induced refractory status epilepticus which was successfully treated with propofol. Chudoku Kenkyu, <b>19<\/b>, 407-408."},{"key":"24","doi-asserted-by":"crossref","unstructured":"Inoue, Y., Kaizaki-Mitsumoto, A. and Numazawa, S. (2022): Toxicokinetic evaluation during intoxication of psychotropic drugs using brain microdialysis in mice. J. Toxicol. Sci., <b>47<\/b>, 99-108.","DOI":"10.2131\/jts.47.99"},{"key":"25","doi-asserted-by":"crossref","unstructured":"Israili, Z.H. and Dayton, P.G. (2001): Human alpha-1-glycoprotein and its interactions with drugs. Drug Metab. Rev., <b>33<\/b>, 161-235.","DOI":"10.1081\/DMR-100104402"},{"key":"26","doi-asserted-by":"crossref","unstructured":"Jolliet-Riant, P., Boukef, M.F., Duch\u00e9, J.C., Simon, N. and Tillement, J.P. (1998): The genetic variant A of human alpha 1-acid glycoprotein limits the blood to brain transfer of drugs it binds. Life Sci., <b>62<\/b>, PL219-PL226.","DOI":"10.1016\/S0024-3205(98)00061-7"},{"key":"27","doi-asserted-by":"publisher","unstructured":"Kulig, K., Rumack, B.H., Sullivan, J.B. Jr., Brandt, H., Spyker, D.A., Duffy, J.P. and Shipe, J.R. (1982): Amoxapine overdose. Coma and seizures without cardiotoxic effects. JAMA, <b>248<\/b>, 1092-1094.","DOI":"10.1001\/jama.1982.03330090062031"},{"key":"28","doi-asserted-by":"publisher","unstructured":"Litovitz, T.L. and Troutman, W.G. (1983): Amoxapine overdose. Seizures and fatalities. JAMA, <b>250<\/b>, 1069-1071.","DOI":"10.1001\/jama.1983.03340080047027"},{"key":"29","doi-asserted-by":"crossref","unstructured":"Lopez, L.M. and Russell, W.L. (1983): Amoxapine overdose: case report and pharmacokinetic profile. J. Toxicol. Clin. Toxicol., <b>20<\/b>, 101-105.","DOI":"10.3109\/15563658308990055"},{"key":"30","doi-asserted-by":"crossref","unstructured":"Mancias, P., Kramer, L. and Butler, I.J. (1995): Amoxapine overdose in a young man: a transient mitochondrial abnormality? Pharmacotherapy, <b>15<\/b>, 528-532.","DOI":"10.1002\/j.1875-9114.1995.tb04393.x"},{"key":"31","doi-asserted-by":"crossref","unstructured":"Merigian, K.S., Browning, R.G. and Leeper, K.V. (1995): Successful treatment of amoxapine-induced refractory status epilepticus with propofol (diprivan). Acad. Emerg. Med., <b>2<\/b>, 128-133.","DOI":"10.1111\/j.1553-2712.1995.tb03177.x"},{"key":"32","doi-asserted-by":"crossref","unstructured":"Miles, M.V., Greenwood, R.S. and Hussey, B. (1990): Diagnostic pitfalls associated with amoxapine overdose: a case report. Am. J. Emerg. Med., <b>8<\/b>, 335-337.","DOI":"10.1016\/0735-6757(90)90090-M"},{"key":"33","doi-asserted-by":"crossref","unstructured":"Miller, M.T., Sleigh, J., Rawlinson, F., de Jongh, R. and Godwin, Y. (1990): Amoxapine overdose: recovery after severe metabolic acidosis (pH 6.69) and status epilepticus. Anaesth. Intensive Care, <b>18<\/b>, 246-248.","DOI":"10.1177\/0310057X9001800217"},{"key":"34","doi-asserted-by":"crossref","unstructured":"Motoya, T., Thevanayagam, L.N., Blaschke, T.F., Au, S., Stone, J.A., Jayewardene, A.L., Chi, J. and Aweeka, F.T. (2006): Characterization of nelfinavir binding to plasma proteins and the lack of drug displacement interactions. HIV Med., <b>7<\/b>, 122-128.","DOI":"10.1111\/j.1468-1293.2006.00356.x"},{"key":"35","unstructured":"National Research Institute of Police Science. (2019-2022): Annual case reports of drug and toxic poisoning in Japan, nos. 61-64 (in japanese). National Police Agency, Kashiwa."},{"key":"36","doi-asserted-by":"crossref","unstructured":"Nosko, M.G., McLean, D.R. and Chin, W.D. (1988): Loss of brainstem and pupillary reflexes in amoxapine overdose: a case report. J. Toxicol. Clin. Toxicol., <b>26<\/b>, 117-122.","DOI":"10.3109\/15563658808995402"},{"key":"37","doi-asserted-by":"crossref","unstructured":"Proudfoot, A.T., Krenzelok, E.P. and Vale, J.A. (2004): Position Paper on urine alkalinization. J. Toxicol. Clin. Toxicol., <b>42<\/b>, 1-26.","DOI":"10.1081\/CLT-120028740"},{"key":"38","doi-asserted-by":"crossref","unstructured":"Rodrigues-Silva, N., Ven\u00e2ncio, \u00c2. and Bou\u00e7a, J. (2013): Risperidone, a risk factor for valproate-induced encephalopathy? Gen. Hosp. Psychiatry., <b>35<\/b>, 452. e5-6.","DOI":"10.1016\/j.genhosppsych.2012.11.009"},{"key":"39","doi-asserted-by":"crossref","unstructured":"Rogol, A.D., Schoumacher, R. and Spyker, D.A. (1984): Generalized convulsions as the presenting sign of amoxapine intoxication. Clin. Pediatr. (Phila.), <b>23<\/b>, 235-237.","DOI":"10.1177\/000992288402300411"},{"key":"40","unstructured":"Ross, S.R. and Rodgers, S.R. (1981): Physostigmine in amoxapine overdose. Am. J. Hosp. Pharm., <b>38<\/b>, 1121-1122."},{"key":"41","doi-asserted-by":"crossref","unstructured":"Schulz, M., Schmoldt, A., Andresen-Streichert, H. and Iwersen-Bergmann, S. (2020): Revisited: therapeutic and toxic blood concentrations of more than 1100 drugs and other xenobiotics. Crit. Care, <b>24<\/b>, 195.","DOI":"10.1186\/s13054-020-02915-5"},{"key":"42","unstructured":"Smith, C.A. (1982): Amoxapine overdose. N. Z. Med. J., <b>95<\/b>, 827."},{"key":"43","doi-asserted-by":"crossref","unstructured":"Sue, Y.J. and Shannon, M. (1992): Pharmacokinetics of drugs in overdose. Clin. Pharmacokinet., <b>23<\/b>, 93-105.","DOI":"10.2165\/00003088-199223020-00003"},{"key":"44","doi-asserted-by":"crossref","unstructured":"Sweeney, K.R., Chapron, D.J., Brandt, J.L., Gomolin, I.H., Feig, P.U. and Kramer, P.A. (1986): Toxic interaction between acetazolamide and salicylate: case reports and a pharmacokinetic explanation. Clin. Pharmacol. Ther., <b>40<\/b>, 518-524.","DOI":"10.1038\/clpt.1986.217"},{"key":"45","doi-asserted-by":"crossref","unstructured":"Tasset, J.J. and Pesce, A.J. (1984): Amoxapine in human overdose. J. Anal. Toxicol., <b>8<\/b>, 124-128.","DOI":"10.1093\/jat\/8.3.124"},{"key":"46","doi-asserted-by":"crossref","unstructured":"Tilstone, W.J., Gray, J.M., Nimmo-Smith, R.H. and Lawson, D.H. (1977): Interaction between warfarin and sulphamethoxazole. Postgrad. Med. J., <b>53<\/b>, 388-390.","DOI":"10.1136\/pgmj.53.621.388"},{"key":"47","doi-asserted-by":"crossref","unstructured":"Wallenburg, E., Klok, B., de Jong, K., de Maat, M., van Erp, N., Stalpers-Konijnenburg, S., Essink, G. and van Luin, M. (2017): Monitoring Protein-Unbound Valproic Acid Serum Concentrations in Clinical Practice. Ther. Drug Monit., <b>39<\/b>, 269-272.","DOI":"10.1097\/FTD.0000000000000405"},{"key":"48","doi-asserted-by":"crossref","unstructured":"Winek, C.L., Wahba, W.W. and Rozin, L. (1984): Amoxapine fatalities: three case studies. Forensic Sci. Int., <b>26<\/b>, 33-38.","DOI":"10.1016\/0379-0738(84)90209-3"}],"container-title":["The Journal of Toxicological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jts\/51\/1\/51_31\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,10]],"date-time":"2026-01-10T04:12:05Z","timestamp":1768018325000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jts\/51\/1\/51_31\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"references-count":48,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.2131\/jts.51.31","relation":{},"ISSN":["0388-1350","1880-3989"],"issn-type":[{"value":"0388-1350","type":"print"},{"value":"1880-3989","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026]]}}}